Pharmaceuticals News and Research

RSS

Counterfeit pharmaceutical products: Practicable and entirely detectable identification with RFID

A detailed product proof and improved security against counterfeiting pharmaceutical products become more and more important, especially nowadays when customers can order their drugs online. The legislative pressure increases primarily for reasons of patient safety, incorrect medications, and drug counterfeiting.

1 Apr 2010

Major breakthrough may help develop low toxicity drugs for sleeping sickness

Scientists from the Drug Discovery Unit at the University of Dundee - working together with partners at the University of York and the Structural Genomics Consortium in Toronto - have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.

1 Apr 2010

New medicines to fight diseases of particular concern to African Americans

A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.

1 Apr 2010

Cord Blood America signs License and Cooperation Agreement with AXM Pharma in China

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has signed a License and Cooperation Agreement for the processing and storage of umbilical cord blood in China with AXM Pharma, Inc.

1 Apr 2010

BioCision, Biohit announce co-promotion program

BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.

31 Mar 2010

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.

31 Mar 2010

RXi Pharmaceuticals reports net loss of 28% for 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported financial results for the fourth quarter and year ended December 31, 2009.

31 Mar 2010

Japanese Patent Office grants Alnylam Pharmaceuticals' claims in second patent application for Tuschl II

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Japanese Patent Office has granted claims in a second patent application (JP Application Number 2006-317758) for the Tuschl II patent series, entitled "RNA Interference Mediating Small RNA Molecules." In May 2008, the Japanese Patent Office granted a related set of claims in the Tuschl II patent series (JP 4 095 895).

31 Mar 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Pfizer Canada is pleased to announce the recipients of its third Neuropathic Pain Research Awards Competition, which aims to fund and support Canadian innovation within independent neuropathic pain research in the areas of basic biomedical, clinical and health sciences.

31 Mar 2010

Astellas Pharma forms agreement to review certain confidential information of OSI Pharmaceuticals

OSI Pharmaceuticals, Inc. today announced that it had entered into an agreement with Astellas Pharma Inc., under which Astellas will be able to review certain confidential information related to OSI.

31 Mar 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

New legislation will increase access to health care, says DDI

Will the newly signed health care legislation create a major shift in how pharmaceutical brand decisions are made? The bill will increase access to health insurance, but many believe the practice of medicine is already in transition, and the bill signed by President Obama will simply accelerate changes already being implemented.

31 Mar 2010

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

When President Obama signed the Patient Protection and Affordable Care Act into law, he ushered in dramatic health care reforms unparalleled since the days of Franklin Delano Roosevelt's New Deal. On April 8, two of the nation's foremost employee benefits and health care law experts from Sonnenschein Nath & Rosenthal LLP, Bruce Fried and Martin Moderson, will present a BNA Tax & Accounting webinar, Health Care Reform – Preparing Employers and Health Plans, directed to professionals who advise employers large and small on employee health care benefits or work with ERISA or non-ERISA health plans.

31 Mar 2010

Investment report on Sunesis Pharmaceuticals

StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

31 Mar 2010

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

GlaxoSmithKline and Isis Pharmaceuticals, Inc. announced today a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new therapeutics against targets for rare and serious disease, including infectious diseases and some conditions causing blindness.

31 Mar 2010

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the fourth quarter of 2009 and for the full year ended December 31, 2009.

31 Mar 2010

Advanced Instruments launches three new levels of Osmometer Standard Solutions

Advanced Instruments is pleased to introduce three new levels of Osmometer Standard Solutions to its product offering. The 200, 400 and 1000 mOsm/kg H20 level standards are NIST- traceable salt solutions that are packaged in 2mL ampules, 10 ampules per box. The kits are available for immediate release.

31 Mar 2010

PhRMA report: 234 medicines in development for special health care needs of children

America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.

31 Mar 2010

CHS receives AAAHC accreditation for two new HybridHealth onsite health centers

Comprehensive Health Services, Inc. (CHS), a leading national workforce health management company specializing in onsite health care solutions, received a coveted accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC) for two of its new HybridHealthSM onsite health centers. In just thirteen months from the completion of construction to their accreditation, the Choose Health Wellness Center at Hewitt Associates in Lincolnshire, Illinois, as well as an onsite health center at a company in Texas, accomplished top ratings in all AAAHC's core standards.

31 Mar 2010

Pharmaceuticals News and Research

Counterfeit pharmaceutical products: Practicable and entirely detectable identification with RFID

Major breakthrough may help develop low toxicity drugs for sleeping sickness

New medicines to fight diseases of particular concern to African Americans

Cord Blood America signs License and Cooperation Agreement with AXM Pharma in China

BioCision, Biohit announce co-promotion program

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

RXi Pharmaceuticals reports net loss of 28% for 2009

Japanese Patent Office grants Alnylam Pharmaceuticals' claims in second patent application for Tuschl II

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Astellas Pharma forms agreement to review certain confidential information of OSI Pharmaceuticals

2010 BIO International Convention to discuss issues that impact drug discovery and development

New legislation will increase access to health care, says DDI

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

Investment report on Sunesis Pharmaceuticals

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Advanced Instruments launches three new levels of Osmometer Standard Solutions

PhRMA report: 234 medicines in development for special health care needs of children

CHS receives AAAHC accreditation for two new HybridHealth onsite health centers

Industry Focus - Biopharma eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence